{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:20:50Z","timestamp":1790644850961,"version":"4.1.0"},"reference-count":520,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.pharmthera.2022.108293","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T21:24:02Z","timestamp":1665177842000},"page":"108293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Is depression the missing link between inflammatory mediators and cancer?"],"prefix":"10.1016","volume":"240","author":[{"given":"Barbara","family":"Polity\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pokorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Wojtukiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Sawicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"My\u015bliwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth V.","family":"Honn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek Z.","family":"Wojtukiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb0005","first-page":"566","article-title":"Prefrontal connectivity and glutamate transmission: Relevance to depression pathophysiology and ketamine treatment","volume":"2","author":"Abdallah","year":"2017","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"issue":"6015","key":"10.1016\/j.pharmthera.2022.108293_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/315103b0","article-title":"High time for psychoimmunology","volume":"315","author":"Ader","year":"1985","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0015","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.37230","article-title":"Comparison of anticancer effects of carbamazepine and valproic acid","volume":"18","author":"Akbarzadeh","year":"2016","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0020","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1210\/jc.2004-1667","article-title":"Major depression is associated with significant diurnal elevations in plasma Interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications","volume":"90","author":"Alesci","year":"2005","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.npbr.2018.10.001","article-title":"Reduction in serum IL-1\u03b2, IL-6, and IL-18 levels and Beck depression inventory-II score by combined sertraline and ketoprofen administration in major depressive disorder: A clinical trial","volume":"30","author":"Al-Hakeim","year":"2018","journal-title":"Neurology Psychiatry and Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.physbeh.2019.05.006","article-title":"The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials","volume":"207","author":"Allison","year":"2019","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0035","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2012.12.002","article-title":"Depression as an evolutionary strategy for defense against infection","volume":"31","author":"Anders","year":"2013","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mpr.138","article-title":"The epidemiology of major depressive episodes: Results from the international consortium of psychiatric epidemiology (ICPE) surveys","volume":"12","author":"Andrade","year":"2003","journal-title":"International Journal of Methods in Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neubiorev.2015.01.018","article-title":"Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response","volume":"51","author":"Andrews","year":"2015","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105149","article-title":"Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes","volume":"126","author":"Anita","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb0060","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.euroneuro.2015.04.016","article-title":"Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: Meta-analysis of absolute prefrontal neuro-metabolic concentrations","volume":"25","author":"Arnone","year":"2015","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0065","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1245\/s10434-012-2793-5","article-title":"Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer","volume":"20","author":"Arrieta","year":"2013","journal-title":"Annals of Surgical Oncology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0070","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1515\/tjb-2019-0010","article-title":"Interleukin-6 signaling pathway involved in major depressive disorder: Selective serotonin reuptake inhibitor regulates IL-6 pathway","volume":"44","author":"Askari","year":"2019","journal-title":"Turkish Journal of Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.mcg.0000210099.36500.fe","article-title":"Interferon-induced depression in chronic hepatitis C: A review of its prevalence, risk factors, biology, and treatment approaches","volume":"40","author":"Asnis","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106385","article-title":"Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases","volume":"147","author":"Atone","year":"2020","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0085","series-title":"Transcultural aspects of somatic symptoms in the context of depressive disorders","first-page":"64","author":"Bagayogo","year":"2013"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jnnp-2019-320912","article-title":"Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: A systematic review and meta-analysis of randomised controlled trials","volume":"91","author":"Bai","year":"2020","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0095","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2014\/10258.5292","article-title":"Oxidative stress and major depression","author":"Bajpai","year":"2014","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.9740\/mhc.2015.05.123","article-title":"Review of antidepressants in the treatment of neuropathic pain","volume":"5","author":"Baltenberger","year":"2015","journal-title":"Mental Health Clinician"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/2230-8229.102311","article-title":"Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients","volume":"19","author":"Bamosa","year":"2012","journal-title":"Journal of Family and Community Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(24)29260-0","article-title":"Intravenous human interleukin-1alpha impairs memory processing in mice: Dependence on blood-brain barrier transport into posterior division of the septum","volume":"299","author":"Banks","year":"2001","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0115","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/S0021-9258(17)43371-0","article-title":"Induction of cystine and glutamate transport activity in human fibroblasts by diethyl maleate and other electrophilic agents","volume":"259","author":"Bannai","year":"1984","journal-title":"The Journal of Biological Chemistry"},{"issue":"31","key":"10.1016\/j.pharmthera.2022.108293_bb0120","doi-asserted-by":"crossref","first-page":"18480","DOI":"10.1016\/S0021-9258(18)51491-5","article-title":"Induction of cystine transport activity in human fibroblasts by oxygen","volume":"264","author":"Bannai","year":"1989","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116362","article-title":"Functional consequences of acute tryptophan depletion on raphe nuclei connectivity and network organization in healthy women","volume":"207","author":"B\u00e4r","year":"2020","journal-title":"NeuroImage"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0130","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-4159.2007.04487.x","article-title":"Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation","volume":"101","author":"Barger","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-017-0311-9","article-title":"Cytokine release syndrome after radiation therapy: Case report and review of the literature","volume":"6","author":"Barker","year":"2018","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11864-022-00954-4","article-title":"Depression and long-term prescription opioid use and opioid use disorder: Implications for pain management in cancer","volume":"23","author":"Bates","year":"2022","journal-title":"Current Treatment Options in Oncology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2014.06.012","article-title":"Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder","volume":"57","author":"Beier","year":"2014","journal-title":"Journal of Psychiatric Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0150","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0278-5846(02)00255-5","article-title":"Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance","volume":"26","author":"Benedetti","year":"2002","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/brainsci8050081","article-title":"Transcranial direct current stimulation (tDCS): A promising treatment for major depressive disorder?","volume":"8","author":"Bennabi","year":"2018","journal-title":"Brain Sciences"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2015.01.010","article-title":"Absence of system xc- in mice decreases anxiety and depressive-like behavior without affecting sensorimotor function or spatial vision","volume":"59","author":"Bentea","year":"2015","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb0165","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jamaoncol.2020.1466","article-title":"Association of mental health treatment with outcomes for US veterans diagnosed with non\u2013small cell lung cancer","volume":"6","author":"Berchuck","year":"2020","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01332","article-title":"Glucocorticoids, sex hormones, and immunity","volume":"9","author":"Bereshchenko","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: Beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/edrv-17-1-64","article-title":"Immune-neuro-endocrine interactions: Facts and hypotheses","volume":"17","author":"Besedovsky","year":"1996","journal-title":"Endocrine Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0190","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: Double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0195","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1176\/appi.ajp.160.10.1890","article-title":"Increase in concentration of waking salivary cortisol in recovered patients with depression","volume":"160","author":"Bhagwagar","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-005-0062-z","article-title":"Increased salivary cortisol after waking in depression","volume":"182","author":"Bhagwagar","year":"2005","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb0205","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","article-title":"Role of oxidative stress in depression","volume":"25","author":"Bhatt","year":"2020","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biopsych.2014.10.014","article-title":"Meta-analysis of cytokines and chemokines in suicidality: Distinguishing suicidal versus nonsuicidal patients","volume":"78","author":"Black","year":"2015","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00269","article-title":"Perceived workplace stress is associated with an increased risk of prostate cancer before age 65","volume":"7","author":"Blanc-Lapierre","year":"2017","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","article-title":"Immune suppression and immune activation in depression","volume":"25","author":"Blume","year":"2011","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0225","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.psychres.2019.06.020","article-title":"Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis","volume":"278","author":"de Boer","year":"2019","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(02)00264-1","article-title":"Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus","volume":"72","author":"Bonaccorso","year":"2002","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2021.100325","article-title":"The role of soluble epoxide hydrolase and its inhibitors in depression","volume":"16","author":"Borsini","year":"2021","journal-title":"Brain, Behavior, & Immunity - Health"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb0240","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ijnp\/pyaa055","article-title":"Pro- and anti-inflammatory properties of interleukin in vitro: Relevance for major depression and human hippocampal neurogenesis","volume":"23","author":"Borsini","year":"2020","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2019.152156","article-title":"Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: A systematic review and meta-analysis","volume":"98","author":"Bottomley","year":"2020","journal-title":"Comprehensive Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0250","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","article-title":"Fatigue and proinflammatory cytokine activity in breast cancer survivors","volume":"64","author":"Bower","year":"2002","journal-title":"Psychosomatic Medicine"},{"issue":"26","key":"10.1016\/j.pharmthera.2022.108293_bb0255","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2011.36.1154","article-title":"Inflammation and behavioral symptoms after breast cancer treatment: Do fatigue, depression, and sleep disturbance share a common underlying mechanism?","volume":"29","author":"Bower","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00044","article-title":"Vagus nerve as modulator of the brain\u2013gut axis in psychiatric and inflammatory disorders","volume":"9","author":"Breit","year":"2018","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0265","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/pr.110.003889","article-title":"Thinking outside the cleft to understand synaptic activity: Contribution of the cystine-glutamate antiporter (system xC\u2212) to normal and pathological glutamatergic signaling","volume":"64","author":"Bridges","year":"2012","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0270","article-title":"The increasing burden of depression","volume":"3","author":"Briley","year":"2011","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb0275","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/pon.1627","article-title":"The association of depression and anxiety with health-related quality of life in cancer patients with depression and\/or pain","volume":"19","author":"Brown","year":"2009","journal-title":"Psycho-Oncology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb0280","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.biopsych.2007.12.007","article-title":"Peripheral inflammation is associated with altered substantia Nigra activity and psychomotor slowing in humans","volume":"63","author":"Brydon","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0285","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchp.2020.07.007","article-title":"Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies","volume":"21","author":"Bueno-Notivol","year":"2021","journal-title":"International Journal of Clinical and Health Psychology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/pon.1022","article-title":"Emotional distress: The sixth vital sign\u2014Future directions in cancer care","volume":"15","author":"Bultz","year":"2006","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: Regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Frontiers in Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0305","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-\u03b1 in cancer patients phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108293_bb0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023285119","article-title":"Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the \u03b17nAChR subunit","volume":"119","author":"Caravaca","year":"2022","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108293_bb0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2008.05.015","article-title":"Subtypes of depression in a nationally representative sample","volume":"113","author":"Carragher","year":"2009","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1745-0179-5-15","article-title":"Adjustment disorder: Epidemiology, diagnosis and treatment","volume":"5","author":"Carta","year":"2009","journal-title":"Clinical Practice and Epidemiology in Mental Health"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0325","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jad.2012.10.036","article-title":"Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system","volume":"148","author":"Carvalho","year":"2013","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0330","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/j.2051-5545.2011.tb00003.x","article-title":"Adjustment disorders: The state of the art","volume":"10","author":"Casey","year":"2011","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0004867416652736","article-title":"Inflammatory cytokines in major depressive disorder: A case\u2013control study","volume":"51","author":"Cassano","year":"2017","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0340","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1017\/S0033291720002032","article-title":"Refining our understanding of depressive states and state transitions in response to cognitive behavioural therapy using latent Markov modelling","volume":"52","author":"Catarino","year":"2022","journal-title":"Psychological Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0345","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/jamapsychiatry.2021.1818","article-title":"Association between mood disorders and risk of COVID-19 infection, hospitalization, and death","volume":"78","author":"Ceban","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.2018.66","article-title":"Treatment-resistant depression and peripheral C-reactive protein","volume":"214","author":"Chamberlain","year":"2019","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0355","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/1381612826666200115100726","article-title":"Inflammatory biomarkers for mood disorders - A brief narrative review","volume":"26","author":"Chang","year":"2020","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0360","series-title":"The Neuroimmunological basis of behavior and mental disorders","first-page":"145","article-title":"Cytokine-induced sickness behavior and depression","author":"Chang","year":"2009"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0365","first-page":"1","article-title":"The roles of thyroid and thyroid hormone in pancreas: Physiology and pathology","volume":"2018","author":"Chen","year":"2018","journal-title":"International Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0370","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.2147\/NDT.S322078","article-title":"The combination of serum BDNF, cortisol and IFN-gamma can assist the diagnosis of major depressive disorder","volume":"17","author":"Chen","year":"2021","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0375","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/j.1471-4159.1990.tb05800.x","article-title":"Uptake of glutamate and cystine in C-6 glioma cells and in cultured astrocytes","volume":"55","author":"Cho","year":"1990","journal-title":"Journal of Neurochemistry"},{"issue":"2_suppl","key":"10.1016\/j.pharmthera.2022.108293_bb0380","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5301\/jsrd.5000265","article-title":"Interleukin-6 as a multifunctional regulator: Inflammation, immune response, and fibrosis","volume":"2","author":"Choy","year":"2017","journal-title":"Journal of Scleroderma and Related Disorders"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0385","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbi.2018.11.007","article-title":"Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort","volume":"76","author":"Chu","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"issue":"10128","key":"10.1016\/j.pharmthera.2022.108293_bb0390","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"The Lancet"},{"issue":"S7","key":"10.1016\/j.pharmthera.2022.108293_bb0395","doi-asserted-by":"crossref","DOI":"10.5694\/j.1326-5377.2009.tb02471.x","article-title":"Depression, anxiety and their relationship with chronic diseases: A review of the epidemiology, risk and treatment evidence","volume":"190","author":"Clarke","year":"2009","journal-title":"Medical Journal of Australia"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0400","doi-asserted-by":"crossref","DOI":"10.1080\/23723556.2017.1344757","article-title":"Inhibiting system xC\u2212 and glutathione biosynthesis \u2013 A potential Achilles\u2019 heel in mutant-p53 cancers","volume":"4","author":"Clemons","year":"2017","journal-title":"Molecular & Cellular Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0405","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41398-021-01668-1","article-title":"Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia","volume":"11","author":"Costi","year":"2021","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1236787","article-title":"The role of the vagus nerve in cancer prognosis: A systematic and a comprehensive review","author":"de Couck","year":"2018","journal-title":"Journal of Oncology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb0415","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/070674371305800802","article-title":"Depression in primary care: Current and future challenges","volume":"58","author":"Craven","year":"2013","journal-title":"The Canadian Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0420","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-061212-171507","article-title":"Depression as a risk factor for cancer: From pathophysiological advances to treatment implications","volume":"65","author":"Currier","year":"2014","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0425","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.psyneuen.2015.02.011","article-title":"Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers","volume":"56","author":"Dahl","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0430","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0435","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12035-016-0356-7","article-title":"Brain barrier breakdown as a cause and consequence of neuroinflammation in sepsis","volume":"55","author":"Danielski","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0440","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.PSY.0000041542.29808.01","article-title":"Association between depression and elevated C-reactive protein","volume":"65","author":"Danner","year":"2003","journal-title":"Psychosomatic Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0445","series-title":"Depression and physical illness","article-title":"Inflammation, sickness behavior and depression","author":"Dantzer","year":"2006"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0450","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: When the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nature Reviews Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0455","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/sj.mp.4000572","article-title":"Cytokines and depression: Fortuitous or causative association?","volume":"4","author":"Dantzer","year":"1999","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0460","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120974169","article-title":"Serum interferon-gamma level is associated with drug-na\u00efve major depressive disorder","volume":"8","author":"Daria","year":"2020","journal-title":"SAGE Open Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0465","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/DMSO.S106797","article-title":"Depression in people with type 2 diabetes: Current perspectives","volume":"11","author":"Darwish","year":"2018","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0470","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.nut.2014.04.001","article-title":"Telomere length and polyunsaturated fatty acids","volume":"30","author":"Das","year":"2014","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0475","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0480","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15622975.2017.1371332","article-title":"Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model","volume":"20","author":"Demuyser","year":"2019","journal-title":"The World Journal of Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0485","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jcem.82.1.3689","article-title":"Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls","volume":"82","author":"Deuschle","year":"1997","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0490","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/ph11030064","article-title":"Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder","volume":"11","author":"Dey","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0495","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jphs.2021.05.002","article-title":"Resolvins as potential candidates for the treatment of major depressive disorder","volume":"147","author":"Deyama","year":"2021","journal-title":"Journal of Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0500","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-017-4774-7","article-title":"Resolvin E1\/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23","volume":"235","author":"Deyama","year":"2018","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0505","first-page":"3","article-title":"Telomere length in healthy adults is positively associated with polyunsaturated fatty acids, including arachidonic acid, and negatively with saturated fatty acids","volume":"76","author":"Dhillon","year":"2021","journal-title":"The Journals of Gerontology: Series A"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0510","first-page":"6","article-title":"G protein-coupled receptor 35: An emerging target in inflammatory and cardiovascular disease","author":"Divorty","year":"2015","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0515","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0520","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"ELife"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0525","doi-asserted-by":"crossref","first-page":"1788899","DOI":"10.1080\/19490976.2020.1788899","article-title":"Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity","volume":"12","author":"Dong","year":"2020","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb0530","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/pon.5192","article-title":"The value of distinct depressive symptoms (PHQ-9) to differentiate depression severity in cancer survivors: An item response approach","volume":"28","author":"Donk","year":"2019","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0535","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0540","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.3390\/ijms18102226","article-title":"Diurnal hypothalamic-pituitary-adrenal axis measures and inflammatory marker correlates in major depressive disorder","volume":"18","author":"Doolin","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0545","series-title":"Modulation of glutamate release from hippocampal mossy fiber nerve endings by arachidonic acid and eicosanoids","first-page":"121","author":"Dorman","year":"1992"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0550","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108293_bb0555","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","article-title":"Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression","volume":"213","author":"Drevets","year":"2008","journal-title":"Brain Structure and Function"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0560","first-page":"14","article-title":"TRP channels role in pain associated with neurodegenerative diseases","author":"Duitama","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb0565","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/appi.ajp.2011.10081163","article-title":"Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: Prospective findings from the heart and soul study","volume":"168","author":"Duivis","year":"2011","journal-title":"American Journal of Psychiatry"},{"issue":"6103","key":"10.1016\/j.pharmthera.2022.108293_bb0570","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: Potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0575","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0580","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030856","article-title":"Management of erectile dysfunction after prostate cancer treatment: Cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK","volume":"9","author":"Dyer","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0585","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00125-014-3224-x","article-title":"Myokines in insulin resistance and type 2 diabetes","volume":"57","author":"Eckardt","year":"2014","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb0590","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41568-021-00395-5","article-title":"Stress and cancer: mechanisms, significance and future directions","volume":"21","author":"Eckerling","year":"2021","journal-title":"Nature Reviews Cancer"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183662","article-title":"Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance","volume":"12","author":"Edwardson","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0600","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jir.2018.0134","article-title":"Estimation of IL-6, INF\u03b3, and lipid profile in suicidal and nonsuicidal adults with major depressive disorder","volume":"39","author":"Eidan","year":"2019","journal-title":"Journal of Interferon & Cytokine Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0605","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.immuni.2022.04.015","article-title":"Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs","volume":"55","author":"Eisenstein","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0610","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/life12020196","article-title":"Novel pharmacological approaches to the treatment of depression","volume":"12","author":"Elias","year":"2022","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0615","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PSY.0b013e31819e333a","article-title":"Depression and C-reactive protein: Population-based health 2000 study","volume":"71","author":"Elovainio","year":"2009","journal-title":"Psychosomatic Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0620","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0625","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/pr.117.014647","article-title":"Neuroimmune axes of the blood\u2013brain barriers and blood\u2013brain interfaces: Bases for physiological regulation, disease states, and pharmacological interventions","volume":"70","author":"Erickson","year":"2018","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0630","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2005.05.001","article-title":"Mood disorders in the medically ill: Scientific review and recommendations","volume":"58","author":"Evans","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0635","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1176\/appi.ajp.159.10.1752","article-title":"Association of depression with Viral Load, CD8 T lymphocytes, and natural killer cells in women with HIV infection","volume":"159","author":"Evans","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0640","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-12-0539","article-title":"Mechanisms in endocrinology: Role of emotional stress in the pathophysiology of Graves\u2019 disease","volume":"168","author":"Falgarone","year":"2013","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0645","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12944-018-0704-x","article-title":"Powdered black cumin seeds strongly improves serum lipids, atherogenic index of plasma and modulates anthropometric features in patients with Hashimoto\u2019s thyroiditis","volume":"17","author":"Farhangi","year":"2018","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0650","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/JPR.S125045","article-title":"Identification of capsazepine as a novel inhibitor of system xC\u2212 and cancer-induced bone pain","volume":"10","author":"Fazzari","year":"2017","journal-title":"Journal of Pain Research"},{"issue":"36","key":"10.1016\/j.pharmthera.2022.108293_bb0655","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1523\/JNEUROSCI.23-36-11427.2003","article-title":"12-lipoxygenase metabolites of arachidonic acid mediate metabotropic glutamate receptor-dependent long-term depression at hippocampal CA3-CA1 synapses","volume":"23","author":"Feinmark","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0660","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0665","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Frontiers in Neuroendocrinology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb0670","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nature Reviews Cardiology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0675","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbrep.2016.12.009","article-title":"Development of a primary microglia screening assay and its use to characterize inhibition of system xc- by erastin and its analogs","volume":"9","author":"Figuera-Losada","year":"2017","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0680","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tics.2014.11.004","article-title":"Dual serotonergic signals: A key to understanding paradoxical effects?","volume":"19","author":"Fischer","year":"2015","journal-title":"Trends in Cognitive Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0685","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmjspcare-2012-000380","article-title":"The relationship between depression and physical symptom burden in advanced cancer","volume":"5","author":"Fitzgerald","year":"2015","journal-title":"BMJ Supportive & Palliative Care"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0690","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-017-0939-x","article-title":"Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro","volume":"14","author":"Fourrier","year":"2017","journal-title":"Journal of Neuroinflammation"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb0695","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1570159X14666160106155129","article-title":"Interferon-related depression: A primer on mechanisms, treatment, and Prevention of a common clinical problem","volume":"14","author":"Franscina Pinto","year":"2016","journal-title":"Current Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0700","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpsycho.2008.03.014","article-title":"The cortisol awakening response (CAR): Facts and future directions","volume":"72","author":"Fries","year":"2009","journal-title":"International Journal of Psychophysiology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/541870","article-title":"Adult neuroplasticity: More than 40 years of research","volume":"2014","author":"Fuchs","year":"2014","journal-title":"Neural Plasticity"},{"issue":"6465","key":"10.1016\/j.pharmthera.2022.108293_bb0710","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.aax5440","article-title":"Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep","volume":"366","author":"Fultz","year":"2019","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb0715","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/intimm\/dxz023","article-title":"Roles of multiple lipid mediators in stress and depression","volume":"31","author":"Furuyashiki","year":"2019","journal-title":"International Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0720","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/cap.2008.0140","article-title":"A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression","volume":"19","author":"Gabbay","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0725","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Advances in Nutrition (Bethesda, Md.)"},{"issue":"05","key":"10.1016\/j.pharmthera.2022.108293_bb0730","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4088\/PCC.v10n0502","article-title":"Relationship of somatic symptoms with depression severity, quality of life, and health resources utilization in patients with major depressive disorder seeking primary health care in Spain","volume":"10","author":"Garc\u00eda-Campayo","year":"2008","journal-title":"The Primary Care Companion to The Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0735","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1073\/pnas.1803999116","article-title":"Suppression of chemotherapy-induced cytokine\/lipid mediator surge and ovarian cancer by a dual COX-2\/sEH inhibitor","volume":"116","author":"Gartung","year":"2019","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0740","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: A systematic analysis for the global burden of disease study 2019","volume":"9","year":"2022","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00122","article-title":"The anti-inflammatory role of omega-3 polyunsaturated fatty acids metabolites in pre-clinical models of psychiatric, neurodegenerative, and neurological disorders","volume":"11","author":"Giacobbe","year":"2020","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0750","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0033291708003723","article-title":"Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study","volume":"39","author":"Gimeno","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0755","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.702617","article-title":"Statins in depression: An evidence-based overview of mechanisms and clinical studies","volume":"12","author":"de Giorgi","year":"2021","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9343(98)00160-0","article-title":"Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome","volume":"105","author":"Glaser","year":"1998","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0765","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejon.2015.06.003","article-title":"Co-occurrence of anxiety and depressive symptoms following breast cancer surgery and its impact on quality of life","volume":"20","author":"Gold","year":"2016","journal-title":"European Journal of Oncology Nursing"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0770","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-1781(82)90015-4","article-title":"\u201cSymptomless\u201d autoimmune thyroiditis in depression","volume":"6","author":"Gold","year":"1982","journal-title":"Psychiatry Research"},{"issue":"21","key":"10.1016\/j.pharmthera.2022.108293_bb0775","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM198605223142101","article-title":"Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing\u2019s disease","volume":"314","author":"Gold","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0780","first-page":"1","article-title":"Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress","author":"Gold","year":"2015","journal-title":"Neural Plasticity, 2015"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0785","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-020-0200-2","article-title":"Comorbid depression in medical diseases","volume":"6","author":"Gold","year":"2020","journal-title":"Nature Reviews. Disease Primers"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb0790","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0795","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2147\/PPA.S127277","article-title":"Relationship between depression and medication adherence in cardiovascular disease: The perfect challenge for the integrated care team","volume":"11","author":"Goldstein","year":"2017","journal-title":"Patient Preference and Adherence"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0800","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jad.2019.07.035","article-title":"Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression","volume":"257","author":"Gopaldas","year":"2019","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0805","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jad.2021.06.001","article-title":"Neuroinflammation in major depressive disorder: A review of PET imaging studies examining the 18-kDa translocator protein","volume":"292","author":"Gritti","year":"2021","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0810","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jpainsymman.2017.04.010","article-title":"Depression\u2014A major contributor to poor quality of life in patients with advanced cancer","volume":"54","author":"Grotmol","year":"2017","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0815","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain, Behavior, and Immunity"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb0820","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11920-013-0400-5","article-title":"Inflammation, heart disease, and depression","volume":"15","author":"Halaris","year":"2013","journal-title":"Current Psychiatry Reports"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb0825","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ajpath.2020.06.010","article-title":"Eicosanoids","volume":"190","author":"Hammock","year":"2020","journal-title":"The American Journal of Pathology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0830","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3988\/jcn.2021.17.4.503","article-title":"How inflammation affects the brain in depression: A review of functional and structural MRI studies","volume":"17","author":"Han","year":"2021","journal-title":"Journal of Clinical Neurology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb0835","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on Serum levels of inflammatory cytokines: A meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0840","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41398-018-0241-4","article-title":"Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia","volume":"8","author":"Haroon","year":"2018","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0845","series-title":"Inflammation effects on brain glutamate in depression: Mechanistic considerations and treatment implications","first-page":"173","author":"Haroon","year":"2016"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0850","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: A trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb0855","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/npp.2014.25","article-title":"IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy","volume":"39","author":"Haroon","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0860","series-title":"Brain structures implicated in inflammation-associated depression","first-page":"221","author":"Harrison","year":"2016"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0865","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/npp.2014.222","article-title":"Effects of inflammation on hippocampus and substantia Nigra responses to novelty in healthy human participants","volume":"40","author":"Harrison","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"5068","key":"10.1016\/j.pharmthera.2022.108293_bb0870","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.1.5068.460","article-title":"Post-influenzal Depression","volume":"1","author":"Harrison","year":"1958","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0875","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","article-title":"Biological basis of the behavior of sick animals","volume":"12","author":"Hart","year":"1988","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0880","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphar.2019.00036","article-title":"Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders","volume":"10","author":"Hashimoto","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0885","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0890","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.10186","article-title":"Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis","volume":"26","author":"Heath","year":"2002","journal-title":"Muscle & Nerve"},{"issue":"feb07 1","key":"10.1016\/j.pharmthera.2022.108293_bb0895","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f165","article-title":"Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116 000 European men and women","volume":"346","author":"Heikkila","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0900","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.psychres.2017.02.056","article-title":"Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study","volume":"252","author":"Hennebelle","year":"2017","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0905","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0022-3956(94)90017-5","article-title":"The combined dexamethasone\/CRH test: A refined laboratory test for psychiatric disorders","volume":"28","author":"Heuser","year":"1994","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb0910","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbi.2012.06.001","article-title":"A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity","volume":"26","author":"Hiles","year":"2012","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0915","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00030","article-title":"Cytokine research in depression: Principles, challenges, and open questions","volume":"10","author":"Himmerich","year":"2019","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0920","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/DNND.S135748","article-title":"Riluzole: Real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis","volume":"7","author":"Hinchcliffe","year":"2017","journal-title":"Degenerative Neurological and Neuromuscular Disease"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0925","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ijnp\/pyy081","article-title":"Circuit mechanisms of reward, anhedonia, and depression","volume":"22","author":"H\u00f6flich","year":"2019","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0930","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","article-title":"Antidepressants and hypothalamic-pituitary-adrenocortical regulation","volume":"17","author":"Holsboer","year":"1996","journal-title":"Endocrine Reviews"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0935","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211006633","article-title":"Distribution of microRNAs associated with major depressive disorder among blood compartments","volume":"49","author":"Homorogan","year":"2021","journal-title":"Journal of International Medical Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0940","first-page":"88","article-title":"Leukocyte telomere length predicts SSRI response in major depressive disorder: A preliminary report","volume":"2","author":"Hough","year":"2016","journal-title":"Molecular Neuropsychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb0945","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosomatic Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0950","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12916-020-01709-4","article-title":"Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: A nationwide register-based cohort study","volume":"18","author":"Hu","year":"2020","journal-title":"BMC Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb0955","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","article-title":"Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial","volume":"7","author":"Husain","year":"2020","journal-title":"The Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0960","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/oxfordjournals.jbchem.a022636","article-title":"Expression of cytokines in bacterial and viral infections and their biochemical aspects","volume":"127","author":"Imanishi","year":"2000","journal-title":"Journal of Biochemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb0965","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00520-013-1767-x","article-title":"Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients","volume":"21","author":"Inagaki","year":"2013","journal-title":"Supportive Care in Cancer"},{"key":"10.1016\/j.pharmthera.2022.108293_bb0970","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2147\/NDT.S159855","article-title":"Elevated peripheral blood glutamate levels in major depressive disorder","volume":"14","author":"Inoshita","year":"2018","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb0975","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41380-019-0501-6","article-title":"Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: The role of cognitive-affective and somatic symptoms","volume":"25","author":"Iob","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb0980","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0889-1591(87)90011-0","article-title":"Impaired natural killer cell activity during bereavement","volume":"1","author":"Irwin","year":"1987","journal-title":"Brain, Behavior, and Immunity"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb0985","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain, Behavior, and Immunity"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0990","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc\u2212 and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb0995","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1000","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2006.09.002","article-title":"Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect","volume":"21","author":"Janicki-Deverts","year":"2007","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1005","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.9969","article-title":"The role of interleukin-6 and inflammatory cytokines in pancreatic cancer-associated depression","author":"Jarrin Jara","year":"2020","journal-title":"Cureus."},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb1010","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/cncr.22294","article-title":"Biomarkers of depression in cancer patients","volume":"107","author":"Jehn","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/1534735410370036","article-title":"Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer","volume":"9","author":"Jehn","year":"2010","journal-title":"Integrative Cancer Therapies"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/bmm.14.114","article-title":"Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses","volume":"9","author":"Jentsch","year":"2015","journal-title":"Biomarkers in Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1025","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: A beginner\u2019s guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamapsychiatry.2015.1977","article-title":"Inflammation and specific symptoms of depression","volume":"73","author":"Jokela","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1040","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2020.43","article-title":"Inflammation as a treatment target in mood disorders: Review","volume":"6","author":"Jones","year":"2020","journal-title":"BJPsych Open"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.prdoa.2021.100104","article-title":"A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson\u2019s disease","volume":"5","author":"Jones","year":"2021","journal-title":"Clinical Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/cpt.134","article-title":"Metabolomic signatures for drug response phenotypes: Pharmacometabolomics enables precision medicine","volume":"98","author":"Kaddurah-Daouk","year":"2015","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: A systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.psychres.2011.12.007","article-title":"Serum concentrations of CRP, IL-6, TNF-\u03b1 and cortisol in major depressive disorder with melancholic or atypical features","volume":"198","author":"Karlovi\u0107","year":"2012","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA axis in major depression: Cortisol, clinical symptomatology and genetic variation predict cognition","volume":"22","author":"Keller","year":"2017","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbi.2021.02.019","article-title":"Depression and interleukin-6 signaling: A Mendelian randomization study","volume":"95","author":"Kelly","year":"2021","journal-title":"Brain, Behavior, and Immunity"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MPA.0000000000001024","article-title":"Early detection of pancreatic cancer","volume":"47","author":"Kenner","year":"2018","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annual Review of Public Health"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb1085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1090","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1017\/S0033291717003038","article-title":"Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: A longitudinal cohort study","volume":"48","author":"Khandaker","year":"2018","journal-title":"Psychological Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb1095","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1176\/appi.ajp.2015.15020152","article-title":"Inflammation: Depression fans the flames and feasts on the heat","volume":"172","author":"Kiecolt-Glaser","year":"2015","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-3999(02)00309-4","article-title":"Depression and immune function","volume":"53","author":"Kiecolt-Glaser","year":"2002","journal-title":"Journal of Psychosomatic Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1017\/neu.2016.68","article-title":"A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats","volume":"29","author":"Kirkedal","year":"2017","journal-title":"Acta Neuropsychiatrica"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: From adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/nu14010037","article-title":"The role of the gut microbiota in the development and progression of major depressive and bipolar disorder","volume":"14","author":"Knuesel","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1120","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1471-4159.1999.0720716.x","article-title":"Antioxidative and Proapoptotic effects of Riluzole on cultured cortical neurons","volume":"72","author":"Koh","year":"1999","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1130","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-017-0632-1","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: Systematic review and meta-analysis","author":"K\u00f6hler","year":"2017","journal-title":"Molecular Neurobiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1135","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb1140","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"Kohler","year":"2016","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1145","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbi.2017.02.020","article-title":"Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression","volume":"62","author":"K\u00f6hler-Forsberg","year":"2017","journal-title":"Brain, Behavior, and Immunity"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/acps.13016","article-title":"Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: Meta-analysis of clinical trials","volume":"139","author":"K\u00f6hler-Forsberg","year":"2019","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb1155","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.biopsych.2019.05.020","article-title":"Role of mesolimbic brain-derived neurotrophic factor in depression","volume":"86","author":"Koo","year":"2019","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1160","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.3390\/ijms22052750","article-title":"Specialized pro-resolving mediators and the lymphatic system","volume":"22","author":"Kraft","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1165","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00059","article-title":"Thyroid hormones and cancer: A comprehensive review of preclinical and clinical studies","volume":"10","author":"Krashin","year":"2019","journal-title":"Frontiers in Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pon.3409","article-title":"Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self-report instruments","volume":"23","author":"Krebber","year":"2014","journal-title":"Psycho-Oncology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1175","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","article-title":"Depression: An inflammatory illness?: figure 1","volume":"83","author":"Krishnadas","year":"2012","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biopsych.2010.05.009","article-title":"Fish oil, blood vessels, and depression","volume":"68","author":"Krishnan","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"7215","key":"10.1016\/j.pharmthera.2022.108293_bb1185","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104371","article-title":"Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study","volume":"109","author":"Kruse","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","article-title":"Anti-inflammatory effects of antidepressants through suppression of the interferon-\u03b3\/interleukin-10 production ratio","volume":"21","author":"Kubera","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00228-009-0650-7","article-title":"The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression","volume":"65","author":"K\u00fc\u00e7\u00fckibrahimo\u011flu","year":"2009","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb1205","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.celrep.2019.04.096","article-title":"An atlas of vagal sensory neurons and their molecular specialization","volume":"27","author":"Kupari","year":"2019","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2891-7-2","article-title":"Nutritional therapies for mental disorders","volume":"7","author":"Lakhan","year":"2008","journal-title":"Nutrition Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb1215","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1017\/S0033291717002483","article-title":"Metabolic and inflammatory markers: Associations with individual depressive symptoms","volume":"48","author":"Lamers","year":"2018","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cells10010100","article-title":"Inflammatory cytokines in cancer: Comprehensive understanding and clinical progress in gene therapy","volume":"10","author":"Lan","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1225","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00249","article-title":"Inflammation-induced tryptophan breakdown is related with anemia, fatigue, and depression in cancer","volume":"11","author":"Lanser","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01696","article-title":"The role of inflammation in depression and fatigue","volume":"10","author":"Lee","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"15","key":"10.1016\/j.pharmthera.2022.108293_bb1240","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003110","article-title":"Incidence of major depressive disorder","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb1245","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/gps.2824","article-title":"Latent class-derived subgroups of depressive symptoms in a community sample of older adults: The Cache County study","volume":"27","author":"Lee","year":"2012","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"31","key":"10.1016\/j.pharmthera.2022.108293_bb1250","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1523\/JNEUROSCI.1625-15.2015","article-title":"The effect of body posture on brain glymphatic transport","volume":"35","author":"Lee","year":"2015","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/pr.119.019026","article-title":"Strategies to modulate MicroRNA functions for the treatment of cancer or organ injury","volume":"72","author":"Lee","year":"2020","journal-title":"Pharmacological Reviews"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb1260","doi-asserted-by":"crossref","first-page":"10041","DOI":"10.3390\/ijms130810041","article-title":"Blood glutamate scavenging: Insight into neuroprotection","volume":"13","author":"Leibowitz","year":"2012","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1265","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0963721420964039","article-title":"From stress to depression: Bringing together cognitive and biological science","volume":"29","author":"LeMoult","year":"2020","journal-title":"Current Directions in Psychological Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/neu.2016.69","article-title":"Inflammation and depression: A causal or coincidental link to the pathophysiology?","volume":"30","author":"Leonard","year":"2018","journal-title":"Acta Neuropsychiatrica"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb1275","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1176\/appi.ajp.157.8.1221","article-title":"Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS","volume":"157","author":"Leserman","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1280","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S0033291702005949","article-title":"Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors","volume":"32","author":"Leserman","year":"2002","journal-title":"Psychological Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1285","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/ijc.23732","article-title":"Chemotherapeutic drugs and human tumor cells cytokine network","volume":"123","author":"Levina","year":"2008","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1290","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000026615","article-title":"Cerebrospinal cytokine levels in patients with acute depression","volume":"40","author":"Levine","year":"1999","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb1295","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0006-3223(99)00284-X","article-title":"Increased cerebrospinal fluid glutamine levels in depressed patients","volume":"47","author":"Levine","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1300","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l1476","article-title":"Accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis","author":"Levis","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1305","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/wps.20199","article-title":"Efficacy and safety of deep transcranial magnetic stimulation for major depression: A prospective multicenter randomized controlled trial","volume":"14","author":"Levkovitz","year":"2015","journal-title":"World Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1310","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system xC\u2212 in health and disease: From molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxidants & Redox Signaling"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb1315","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0706743720974832","article-title":"Depression as a risk factor for physical illness and multimorbidity in a cohort with no prior comorbidity","volume":"66","author":"Li","year":"2021","journal-title":"The Canadian Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1320","article-title":"Blood inflammatory cytokines as predictors of depression in patients with glioma","volume":"13","author":"Li","year":"2022","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1325","article-title":"Zinc intakes and health outcomes: An umbrella review","volume":"9","author":"Li","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1330","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/pon.4316","article-title":"Pro- and anti-inflammatory cytokine associations with major depression in cancer patients","volume":"26","author":"Li","year":"2017","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jpsychires.2019.05.018","article-title":"MicroRNA-140-5p: A novel circulating biomarker for early warning of late-onset post-stroke depression","volume":"115","author":"Liang","year":"2019","journal-title":"Journal of Psychiatric Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1340","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","article-title":"Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations","volume":"129","author":"Lichtman","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1345","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/s41598-018-21243-x","article-title":"Prevalence of depression in the community from 30 countries between 1994 and 2014","volume":"8","author":"Lim","year":"2018","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1350","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2010.03.018","article-title":"A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression","volume":"68","author":"Lin","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopsych.2009.01.030","article-title":"Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity","volume":"66","author":"Lindqvist","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1360","doi-asserted-by":"crossref","first-page":"14844","DOI":"10.1038\/ncomms14844","article-title":"Inhibiting the system xC\u2212\/glutathione axis selectively targets cancers with mutant-p53 accumulation","volume":"8","author":"Liu","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1365","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00552","article-title":"The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder","volume":"9","author":"Liu","year":"2018","journal-title":"Frontiers in Psychiatry"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb1370","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","article-title":"xCT: A critical molecule that links cancer metabolism to redox Signaling","volume":"28","author":"Liu","year":"2020","journal-title":"Molecular Therapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1375","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","article-title":"System Xc\u2212: A key regulatory target of ferroptosis in cancer","volume":"39","author":"Liu","year":"2021","journal-title":"Investigational New Drugs"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1380","first-page":"1","article-title":"The role of neural plasticity in depression: From hippocampus to prefrontal cortex","volume":"2017","author":"Liu","year":"2017","journal-title":"Neural Plasticity"},{"issue":"23","key":"10.1016\/j.pharmthera.2022.108293_bb1385","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1007\/s00216-016-9768-5","article-title":"Plasma lipidomics reveals potential lipid markers of major depressive disorder","volume":"408","author":"Liu","year":"2016","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1390","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.779306","article-title":"Associations of maternal polyunsaturated fatty acids with telomere length in the cord blood and placenta in Chinese population","volume":"8","author":"Liu","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"45","key":"10.1016\/j.pharmthera.2022.108293_bb1395","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002033","article-title":"Antidepressant effects of electroconvulsive therapy correlate with subgenual anterior cingulate activity and connectivity in depression","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1400","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"Journal of Affective Disorders"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb1405","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.biopsych.2006.02.016","article-title":"The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study","volume":"60","author":"Liukkonen","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1410","doi-asserted-by":"crossref","first-page":"417","DOI":"10.31887\/DCNS.2009.11.4\/felotrich","article-title":"Major depression during interferon-alpha treatment: Vulnerability and prevention","volume":"11","author":"Lotrich","year":"2009","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1415","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jad.2020.06.070","article-title":"Risk of depressive symptoms before and after the first hospitalisation for cancer: Evidence from a 16-year cohort study in the Czech Republic","volume":"276","author":"Lu","year":"2020","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archopht.1957.00940010205006","article-title":"The toxic effect of sodium L-glutamate on the inner layers of the retina","volume":"58","author":"Lucas","year":"1957","journal-title":"A.M.A. Archives of Ophthalmology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1425","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/PSY.0b013e318235be76","article-title":"Biobehavioral factors and cancer progression","volume":"73","author":"Lutgendorf","year":"2011","journal-title":"Psychosomatic Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb1430","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1017\/S0033291709992157","article-title":"Deconstructing major depression: A validation study of the DSM-IV symptomatic criteria","volume":"40","author":"Lux","year":"2010","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1435","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neubiorev.2011.05.014","article-title":"Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings","volume":"36","author":"Luykx","year":"2012","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1440","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.00064","article-title":"Vagus nerve stimulation for depression: A systematic review","volume":"10","author":"Lv","year":"2019","journal-title":"Frontiers in Psychology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1445","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109023","article-title":"Inflammation at the crossroads of COVID-19, cognitive deficits and depression","volume":"209","author":"Lyra e Silva","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1450","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.11.039","article-title":"Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review","volume":"209","author":"Machado","year":"2017","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1455","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00561","article-title":"Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer\u2019s disease and depression","volume":"9","author":"Madeira","year":"2018","journal-title":"Frontiers in Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1460","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","article-title":"Negative immunoregulatory effects of antidepressants inhibition of interferon-\u03b3 and stimulation of interleukin-10 secretion","volume":"20","author":"Maes","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1465","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","article-title":"Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression","volume":"35","author":"Maes","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1470","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1741-7015-10-66","article-title":"Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways","volume":"10","author":"Maes","year":"2012","journal-title":"BMC Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb1475","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb1480","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.150.8.1189","article-title":"Interleukin-1 beta: A putative mediator of HPA axis hyperactivity in major depression?","volume":"150","author":"Maes","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1485","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","article-title":"Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression","volume":"34","author":"Maes","year":"1995","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1490","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-1781(93)90081-Q","article-title":"Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobinemia during major depression","volume":"47","author":"Maes","year":"1993","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1495","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0278-5846(92)90056-K","article-title":"Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness","volume":"16","author":"Maes","year":"1992","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1500","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(94)90003-5","article-title":"Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response","volume":"54","author":"Maes","year":"1994","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1505","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2019.100800","article-title":"Inflammation and the dimensions of depression: A review","volume":"56","author":"Majd","year":"2020","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1515","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jad.2017.08.022","article-title":"The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative review","volume":"225","author":"Manoliu","year":"2018","journal-title":"Journal of Affective Disorders"},{"issue":"36","key":"10.1016\/j.pharmthera.2022.108293_bb1520","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.2174\/138161212803523554","article-title":"The role of oxidative stress in depressive disorders","volume":"18","author":"Maria Michel","year":"2012","journal-title":"Current Pharmaceutical Design"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1525","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.14-260323","article-title":"Noncoding RNAs, cytokines, and inflammation-related diseases","volume":"29","author":"Marques-Rocha","year":"2015","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/da.20876","article-title":"Proinflammatory and \u201cresiliency\u201d proteins in the CSF of patients with major depression","volume":"29","author":"Martinez","year":"2012","journal-title":"Depression and Anxiety"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1535","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jnc.13348","article-title":"Main path and byways: Non-vesicular glutamate release by system xC\u2212 as an important modifier of glutamatergic neurotransmission","volume":"135","author":"Massie","year":"2015","journal-title":"Journal of Neurochemistry"},{"issue":"32","key":"10.1016\/j.pharmthera.2022.108293_bb1540","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jncimonographs\/lgh014","article-title":"Prevalence of depression in patients with cancer","volume":"2004","author":"Massie","year":"2004","journal-title":"Journal of the National Cancer Institute Monographs"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1545","first-page":"1690","article-title":"Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans","volume":"77","author":"Mastorakos","year":"1993","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1550","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1196\/annals.1418.005","article-title":"Glutamate and neurotrophic factors in neuronal plasticity and disease","volume":"1144","author":"Mattson","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1555","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"19","key":"10.1016\/j.pharmthera.2022.108293_bb1560","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.3390\/molecules25194466","article-title":"Polyunsaturated fatty acids of both the omega-3 and the omega-6 family abrogate the cytokine-induced upregulation of miR-29a-3p by endothelial cells","volume":"25","author":"Maucher","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb1565","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/pon.4133","article-title":"Depression and healthcare service utilization in patients with cancer","volume":"26","author":"Mausbach","year":"2017","journal-title":"Psycho-Oncology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1570","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cmet.2022.04.001","article-title":"Microbiota alterations in proline metabolism impact depression","volume":"34","author":"Mayneris-Perxachs","year":"2022","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1575","first-page":"291","article-title":"Life stressors as risk factors in depression","volume":"5","author":"Mazure","year":"1998","journal-title":"Clinical Psychology: Science and Practice"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1580","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.mehy.2012.02.009","article-title":"Glutamate-based depression GBD","volume":"78","author":"McCarthy","year":"2012","journal-title":"Medical Hypotheses"},{"issue":"13","key":"10.1016\/j.pharmthera.2022.108293_bb1585","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.34193","article-title":"Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis","volume":"128","author":"McFarland","year":"2022","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1590","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","article-title":"Social stress induces neurovascular pathology promoting depression","volume":"20","author":"Menard","year":"2017","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1595","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00101","article-title":"Is the HPA axis as target for depression outdated, or is there a new hope?","volume":"10","author":"Menke","year":"2019","journal-title":"Frontiers in Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1600","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.21234","article-title":"Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome","volume":"104","author":"Meyers","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","article-title":"Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface","volume":"23","author":"Miller","year":"2009","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2009.09.009","article-title":"Depression and immunity: A role for T cells?","volume":"24","author":"Miller","year":"2010","journal-title":"Brain, Behavior, and Immunity"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1615","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depression and Anxiety"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1620","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb1625","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2215-0366(20)30357-6","article-title":"Trial failures of anti-inflammatory drugs in depression","volume":"7","author":"Miller","year":"2020","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1630","series-title":"Effects of cytokines on glucocorticoid receptor expression and function","first-page":"107","author":"Miller","year":"1999"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1635","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: From evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1640","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1467-8721.2006.00450.x","article-title":"Turning up the heat","volume":"15","author":"Miller","year":"2006","journal-title":"Current Directions in Psychological Science"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1645","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0002-9149(02)02863-1","article-title":"Clinical depression and inflammatory risk markers for coronary heart disease","volume":"90","author":"Miller","year":"2002","journal-title":"The American Journal of Cardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1650","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1460-9568.2008.06470.x","article-title":"Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice","volume":"28","author":"Mingam","year":"2008","journal-title":"European Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1655","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"The Lancet Oncology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb1660","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1523\/JNEUROSCI.3770-03.2004","article-title":"Vesicular glutamate transporter-dependent glutamate release from astrocytes","volume":"24","author":"Montana","year":"2004","journal-title":"Journal of Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1665","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2217\/fon.10.142","article-title":"Impact of stress on cancer metastasis","volume":"6","author":"Moreno-Smith","year":"2010","journal-title":"Future Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1670","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.psy.0000149259.72488.09","article-title":"Inflammatory markers and sleep disturbance in major depression","volume":"67","author":"Motivala","year":"2005","journal-title":"Psychosomatic Medicine"},{"issue":"9590","key":"10.1016\/j.pharmthera.2022.108293_bb1675","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: Results from the world health surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1680","doi-asserted-by":"crossref","first-page":"507","DOI":"10.9758\/cpn.2020.18.4.507","article-title":"Kynurenine pathway of tryptophan metabolism in neuropsychiatric disorders: Pathophysiologic and therapeutic considerations","volume":"18","author":"Muneer","year":"2020","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2022.108293_bb1685","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine\u2013serotonin interaction through IDO: A neurodegeneration hypothesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Medical Hypotheses"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195151","article-title":"Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma","volume":"13","author":"Nagane","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1695","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.585534","article-title":"Depression and anxiety in patients with cancer: A cross-sectional study","volume":"12","author":"Naser","year":"2021","journal-title":"Frontiers in Psychology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1700","doi-asserted-by":"crossref","first-page":"41382","DOI":"10.1038\/srep41382","article-title":"Behavioural effects of using sulfasalazine to inhibit glutamate released by cancer cells: A novel target for cancer-induced depression","volume":"7","author":"Nashed","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1705","author":"National Center for Biotechnology Information"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1710","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.3390\/ijms19123851","article-title":"The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases","volume":"19","author":"Neavin","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb1715","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","article-title":"Rheumatoid arthritis and depression: An inflammatory perspective","volume":"6","author":"Nerurkar","year":"2019","journal-title":"The Lancet Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2022.108293_bb1720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.07.034","article-title":"The prevalence and pharmacotherapy of depression in cancer patients","volume":"131","author":"Ng","year":"2011","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1725","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12885-019-6181-4","article-title":"Depression and anxiety among people living with and beyond cancer: A growing clinical and research priority","volume":"19","author":"Niedzwiedz","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1730","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2147\/JIR.S317182","article-title":"Anti-inflammatory effects of four psilocybin-containing magic mushroom water extracts in vitro on 15-lipoxygenase activity and on lipopolysaccharide-induced cyclooxygenase-2 and inflammatory cytokines in human U937 macrophage cells","volume":"14","author":"Nkadimeng","year":"2021","journal-title":"Journal of Inflammation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1735","first-page":"104","article-title":"The effects of Nigella sativa on sickness behavior induced by lipopolysaccharide in male Wistar rats","volume":"6","author":"Norouzi","year":"2016","journal-title":"Avicenna Journal of Phytomedicine"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2022.108293_bb1740","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","article-title":"Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy","volume":"41","author":"O\u2019Brien","year":"2007","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb1745","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/jn\/107.7.1222","article-title":"Analogous effects of zinc deficiency and aspirin toxicity in the pregnant rat","volume":"107","author":"O\u2019Dell","year":"1977","journal-title":"The Journal of Nutrition"},{"issue":"14","key":"10.1016\/j.pharmthera.2022.108293_bb1750","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.3390\/ijerph16142537","article-title":"Adjustment disorder: Current developments and future directions","volume":"16","author":"O\u2019Donnell","year":"2019","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1755","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2018.08.028","article-title":"Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence","volume":"105","author":"Ogawa","year":"2018","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1760","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: A systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1765","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bjc.6600786","article-title":"Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines","volume":"88","author":"Okuno","year":"2003","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1770","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2019.01.029","article-title":"Lipid dynamics in LPS-induced neuroinflammation by DESI-MS imaging","volume":"79","author":"Oliveira-Lima","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1775","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/088307388900400315","article-title":"Glutamate, a neurotoxic transmitter","volume":"4","author":"Olney","year":"1989","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1780","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pbb.2017.08.003","article-title":"Fluoxetine coupled with zinc in a chronic mild stress model of depression: Providing a reservoir for optimum zinc signaling and neuronal remodeling","volume":"160","author":"Omar","year":"2017","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1785","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.placenta.2018.11.010","article-title":"Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT\/SLC7A11 in human placental BeWo cells","volume":"75","author":"Ono","year":"2019","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1790","first-page":"54","article-title":"Vagus nerve stimulation (VNS) and treatment of depression: To the brainstem and beyond","volume":"3","author":"O\u2019Reardon","year":"2006","journal-title":"Psychiatry (Edgmont (Pa.\u202f: Township))"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb1795","first-page":"735","article-title":"The emerging role of docosahexaenoic acid in neuroinflammation","volume":"9","author":"Orr","year":"2008","journal-title":"Current Opinion in Investigational Drugs (London, England : 2000)"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1800","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: A systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1805","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1810","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00431","article-title":"Depression and obesity: Integrating the role of stress, neuroendocrine dysfunction and inflammatory pathways","volume":"9","author":"Ouakinin","year":"2018","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1815","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2009.04984.x","article-title":"Cytokines and glucocorticoid receptor Signaling","volume":"1179","author":"Pace","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1820","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/aps.2017.207","article-title":"Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression","volume":"39","author":"Pan","year":"2018","journal-title":"Acta Pharmacologica Sinica"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb1825","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: Classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends in Neurosciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1830","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","article-title":"Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment","volume":"49","author":"Pariante","year":"2001","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1835","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ddr.21557","article-title":"Novel analogs of sulfasalazine as system xC\u2212 antiporter inhibitors: Insights from the molecular modeling studies","volume":"80","author":"Patel","year":"2019","journal-title":"Drug Development Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1840","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0253-7176.112193","article-title":"Adjustment disorder: Current diagnostic status","volume":"35","author":"Patra","year":"2013","journal-title":"Indian Journal of Psychological Medicine"},{"issue":"s377","key":"10.1016\/j.pharmthera.2022.108293_bb1845","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0447.1994.tb05803.x","article-title":"Life events, social support and depression","volume":"89","author":"Paykel","year":"1994","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1850","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-0447.108.s418.13.x","article-title":"Life events and affective disorders","volume":"108","author":"Paykel","year":"2003","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2022.108293_bb1855","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.physbeh.2009.02.040","article-title":"Prostaglandins and sickness behavior: Old story, new insights","volume":"97","author":"Pecchi","year":"2009","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1860","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neubiorev.2016.07.003","article-title":"Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms","volume":"74","author":"Penninx","year":"2017","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"572","key":"10.1016\/j.pharmthera.2022.108293_bb1865","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5817","article-title":"Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils","volume":"12","author":"Perego","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1870","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/life10050070","article-title":"Subtypes of depression: Latent class analysis in Spanish old people with depressive symptoms","volume":"10","author":"P\u00e9rez-Belmonte","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1875","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.657004","article-title":"Immunological interfaces: The COVID-19 pandemic and depression","volume":"12","author":"Perlmutter","year":"2021","journal-title":"Frontiers in Neurology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb1880","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: A meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb1885","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/ijms23042032","article-title":"Adaptation of lipid profiling in depression disease and treatment: A critical review","volume":"23","author":"Pinto","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1890","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k1415","article-title":"Depression and anxiety in patients with cancer","author":"Pitman","year":"2018","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb1895","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/acn3.51240","article-title":"The role of bioactive lipids in attenuating the neuroinflammatory cascade in traumatic brain injury","volume":"7","author":"Poblete","year":"2020","journal-title":"Annals of Clinical Translational Neurology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1900","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.590095","article-title":"Proinflammatory cytokines predict brain metabolite concentrations in the anterior cingulate cortex of patients with bipolar disorder","volume":"11","author":"Poletti","year":"2020","journal-title":"Frontiers in Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1905","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00406-021-01346-9","article-title":"Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: Role of depression and impact on quality of life","volume":"272","author":"Poletti","year":"2022","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1910","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120162","article-title":"Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis","volume":"434","author":"Premraj","year":"2022","journal-title":"Journal of the Neurological Sciences"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108293_bb1915","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1073\/pnas.0811949106","article-title":"Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation","volume":"106","author":"Pyter","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1920","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/jrms.jrms_823_21","article-title":"Nigella sativa extract in the treatment of depression and serum brain-derived neurotrophic factor (BDNF) levels","volume":"27","author":"Rafiee Zadeh","year":"2022","journal-title":"Journal of Research in Medical Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1925","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: Inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends in Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb1930","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-3223(03)00413-X","article-title":"Depression in cancer: New developments regarding diagnosis and treatment","volume":"54","author":"Raison","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb1935","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","article-title":"Is depression an inflammatory disorder?","volume":"13","author":"Raison","year":"2011","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5272741","article-title":"Relevance of alternative routes of Kynurenic acid production in the brain","volume":"2018","author":"Ramos-Ch\u00e1vez","year":"2018","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1945","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: A proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1950","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fnbeh.2016.00231","article-title":"Disruption of the glutamate-glutamine cycle involving astrocytes in an animal model of depression for males and females","volume":"10","author":"Rappeneau","year":"2016","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1955","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2017.06.009","article-title":"Multimorbidity and depression: A systematic review and meta-analysis","volume":"221","author":"Read","year":"2017","journal-title":"Journal of Affective Disorders"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb1960","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","article-title":"Stress, depression, the immune system, and cancer","volume":"5","author":"Reiche","year":"2004","journal-title":"The Lancet Oncology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1965","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1970","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1096\/fj.201600896","article-title":"Omega-3 polyunsaturated fatty acids promote amyloid-\u03b2 clearance from the brain through mediating the function of the glymphatic system","volume":"31","author":"Ren","year":"2017","journal-title":"The FASEB Journal"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2022.108293_bb1975","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1980","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00521","article-title":"Depression as a glial-based synaptic dysfunction","volume":"9","author":"Rial","year":"2016","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb1985","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1078-0432.CCR-04-2000","article-title":"Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer","volume":"11","author":"Rich","year":"2005","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb1990","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2407-9-372","article-title":"Early termination of ISRCTN45828668, a phase 1\/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults","volume":"9","author":"Robe","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2022.108293_bb1995","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.591071","article-title":"The holobiont blindspot: Relating host-microbiome interactions to cognitive biases and the concept of the \u201cumwelt.\u201d","volume":"11","author":"Robinson","year":"2020","journal-title":"Frontiers in Psychology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2000","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/ijms18020284","article-title":"Impact of polyunsaturated fatty acids on miRNA profiles of monocytes\/macrophages and endothelial cells\u2014A pilot study","volume":"18","author":"Roessler","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb2005","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"International Journal of Biological Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2010","first-page":"57","article-title":"Excitotoxicity and the NMDA receptor--still lethal after eight years","volume":"18","author":"Rothman","year":"1995","journal-title":"Trends in Neurosciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.14336\/AD.2014.0423","article-title":"The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer\u2019s disease","volume":"6","author":"Rudy","year":"2015","journal-title":"Aging and Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2020","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2020.12.040","article-title":"Functional characterization of the dural sinuses as a neuroimmune interface","volume":"184","author":"Rustenhoven","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jad.2019.06.065","article-title":"Longer-term open-label study of adjunctive riluzole in treatment-resistant depression","volume":"258","author":"Sakurai","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1196\/annals.1300.018","article-title":"Clinical studies implementing glutamate neurotransmission in mood disorders","volume":"1003","author":"Sanacora","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"issue":"10312","key":"10.1016\/j.pharmthera.2022.108293_bb2040","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2045","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.637863","article-title":"Glutamate and GABA homeostasis and neurometabolism in major depressive disorder","volume":"12","author":"Sarawagi","year":"2021","journal-title":"Frontiers in Psychiatry"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108293_bb2050","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients","volume":"115","author":"Satin","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/bj3100547","article-title":"Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide","volume":"310","author":"Sato","year":"1995","journal-title":"Biochemical Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbrc.2004.10.009","article-title":"Transcriptional control of cystine\/glutamate transporter gene by amino acid deprivation","volume":"325","author":"Sato","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb2065","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","article-title":"Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement","volume":"57","author":"Schaefer","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mcn.2018.05.002","article-title":"Functional organization of postsynaptic glutamate receptors","volume":"91","author":"Scheefhals","year":"2018","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb2075","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2014.04.021","article-title":"Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity","volume":"55","author":"Schmidt","year":"2014","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neubiorev.2016.06.002","article-title":"Lipids in psychiatric disorders and preventive medicine","volume":"76","author":"Schneider","year":"2017","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13058-016-0733-1","article-title":"Psychological stress, adverse life events and breast cancer incidence: A cohort investigation in 106,000 women in the United Kingdom","volume":"18","author":"Schoemaker","year":"2016","journal-title":"Breast Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2095","series-title":"Madhouse: A tragic tale of megalomania and modern medicine","author":"Scull","year":"2005"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb2100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","article-title":"Blood\u2013brain barrier dynamics to maintain brain homeostasis","volume":"44","author":"Segarra","year":"2021","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1037\/0033-2909.130.4.601","article-title":"Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry","volume":"130","author":"Segerstrom","year":"2004","journal-title":"Psychological Bulletin"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1139\/Y09-129","article-title":"A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes. This review is one of a selection of papers published in a special issue on oxidative stress in health and disease","volume":"88","author":"Seidlitz","year":"2010","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb2115","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1038\/s41380-021-01202-1","article-title":"Ependymal cells-CSF flow regulates stress-induced depression","volume":"26","author":"Seo","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2021.100035","article-title":"The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behavior","volume":"5","author":"Serafini","year":"2021","journal-title":"Biomarkers in Neuropsychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2020.07.066","article-title":"Antidepressant effects of ketamine and ECT: A pilot comparison","volume":"276","author":"Sharma","year":"2020","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajpa.22698","article-title":"Human sickness behavior: Ultimate and proximate explanations","volume":"157","author":"Shattuck","year":"2015","journal-title":"American Journal of Physical Anthropology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpsychires.2015.09.001","article-title":"The pro-inflammatory profile of depressed patients is (partly) related to obesity","volume":"70","author":"Shelton","year":"2015","journal-title":"Journal of Psychiatric Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pneurobio.2010.04.004","article-title":"Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression","volume":"91","author":"Shelton","year":"2010","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.31887\/DCNS.2011.13.1\/rshelton","article-title":"Inflammation in depression: Is adiposity a cause?","volume":"13","author":"Shelton","year":"2011","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10120-016-0610-8","article-title":"Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)","volume":"20","author":"Shitara","year":"2017","journal-title":"Gastric Cancer"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb2160","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/da.22938","article-title":"Adherence to antidepressant medications is associated with reduced premature mortality in patients with cancer: A nationwide cohort study","volume":"36","author":"Shoval","year":"2019","journal-title":"Depression and Anxiety"},{"issue":"20","key":"10.1016\/j.pharmthera.2022.108293_bb2165","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1016\/j.bmcl.2011.07.081","article-title":"Inhibition of transporter-mediated cystine uptake by sulfasalazine analogs","volume":"21","author":"Shukla","year":"2011","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb2170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1615\/CritRevImmunol.2018026750","article-title":"Function of pro-resolving lipid mediator Resolvin E1 in type 2 diabetes","volume":"38","author":"Sima","year":"2018","journal-title":"Critical Reviews in Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb2175","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/da.23161","article-title":"Depression subtypes and their response to cognitive behavioral therapy: A latent transition analysis","volume":"38","author":"Simmonds-Buckley","year":"2021","journal-title":"Depression and Anxiety"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41419-018-0351-1","article-title":"Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation","volume":"9","author":"Sim\u00f5es","year":"2018","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in major depressive disorder","volume":"18","author":"Simon","year":"2008","journal-title":"European Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.arr.2010.11.002","article-title":"Inflammatory markers in population studies of aging","volume":"10","author":"Singh","year":"2011","journal-title":"Ageing Research Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2195","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1037\/a0035302","article-title":"From stress to inflammation and major depressive disorder: A social signal transduction theory of depression","volume":"140","author":"Slavich","year":"2014","journal-title":"Psychological Bulletin"},{"issue":"49","key":"10.1016\/j.pharmthera.2022.108293_bb2200","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1038\/onc.2015.60","article-title":"Drug repurposing: Sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc\u2212, leading to glutathione depletion","volume":"34","author":"Sleire","year":"2015","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb2205","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.4088\/JCP.14m09147","article-title":"Depression and multimorbidity","volume":"75","author":"Smith","year":"2014","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2210","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3892\/ol.2015.2944","article-title":"Depression in cancer patients: Pathogenesis, implications and treatment (review)","volume":"9","author":"Smith","year":"2015","journal-title":"Oncology Letters"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ypmed.2005.11.005","article-title":"\u03c9-3 polyunsaturated fatty acids and depression: A review of the evidence and a methodological critique","volume":"42","author":"Sontrop","year":"2006","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3614960","article-title":"Antidepressant and antiaging effects of A\u00e7a\u00ed ( Euterpe oleracea Mart.) in mice","volume":"2019","author":"Souza-Monteiro","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb2230","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.pnpbp.2007.05.001","article-title":"Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder","volume":"31","author":"Soygur","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-3223(03)00566-3","article-title":"Depression and cancer: Mechanisms and disease progression","volume":"54","author":"Spiegel","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb2240","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2174\/1570159X20666211223130228","article-title":"Biomedical perspectives of acute and chronic neurological and neuropsychiatric sequelae of COVID-19","volume":"20","author":"Stefano","year":"2022","journal-title":"Current Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12888-020-02546-8","article-title":"Mental and somatic comorbidity of depression: A comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data","volume":"20","author":"Steffen","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2250","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"Journal of Neuroinflammation"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb2255","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbi.2009.04.011","article-title":"A prospective evaluation of the directionality of the depression\u2013inflammation relationship","volume":"23","author":"Stewart","year":"2009","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2260","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbi.2015.05.008","article-title":"Depression as sickness behavior? A test of the host defense hypothesis in a high pathogen population","volume":"49","author":"Stieglitz","year":"2015","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246592","article-title":"Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment","volume":"16","author":"Stirton","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2270","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2147\/NDT.S114542","article-title":"Biomarkers for depression: Recent insights, current challenges and future prospects","volume":"13","author":"Strawbridge","year":"2017","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2275","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neubiorev.2011.10.001","article-title":"Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity","volume":"36","author":"Stuart","year":"2012","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/healthcare10020333","article-title":"Lipid biomarkers in depression: Does antidepressant therapy have an impact?","volume":"10","author":"Stuchtey","year":"2022","journal-title":"Healthcare"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2022.108293_bb2285","first-page":"151","article-title":"Mind-body interface: The role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression","volume":"17","author":"Su","year":"2008","journal-title":"Asia Pacific Journal of Clinical Nutrition"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2290","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000198167","article-title":"Biological mechanism of antidepressant effect of omega\u20133 fatty acids: How does fish oil act as a \u2018mind-body Interface\u2019?","volume":"17","author":"Su","year":"2009","journal-title":"Neurosignals"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2295","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3892\/ol.2020.11813","article-title":"xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma","volume":"20","author":"Sugiyama","year":"2020","journal-title":"Oncology Letters"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2018.01.010","article-title":"Metabolic\/inflammatory\/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target","volume":"87","author":"Swardfager","year":"2018","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ijc.2910540117","article-title":"12(S)-hete promotes tumor-cell adhesion by increasing surface expression of \u03b1V\u03b23 integrins on endothelial cells","volume":"54","author":"Tang","year":"1993","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2310","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s13311-020-00892-9","article-title":"Neuromodulation, specialized proresolving mediators, and resolution of pain","volume":"17","author":"Tao","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2315","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/jcb.26512","article-title":"Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors","volume":"119","author":"Tarasenko","year":"2018","journal-title":"Journal of Cellular Biochemistry"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2022.108293_bb2320","first-page":"220","article-title":"The role of eicosanoids in the brain","volume":"17","author":"Tassoni","year":"2008","journal-title":"Asia Pacific Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2325","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105026","article-title":"Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders","volume":"159","author":"Thapak","year":"2020","journal-title":"Pharmacological Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb2330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127785","article-title":"High-throughput assay development for cystine-glutamate antiporter (xc-) highlights faster cystine uptake than glutamate release in glioma cells","volume":"10","author":"Thomas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2335","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.673549","article-title":"Specialized pro-resolving lipid mediators and glial cells: Emerging candidates for brain homeostasis and repair","volume":"15","author":"Tiberi","year":"2021","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2340","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mehy.2015.01.002","article-title":"Measuring sickness behavior in the context of pancreatic cancer","volume":"84","author":"Tobias","year":"2015","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2345","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.744318","article-title":"Factors associated with dysfunction of glymphatic system in patients with glioma","volume":"11","author":"Toh","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb2350","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.3390\/app10103455","article-title":"Mast cells, astrocytes, arachidonic acid: Do they play a role in depression?","volume":"10","author":"Traina","year":"2020","journal-title":"Applied Sciences"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108293_bb2355","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.pain.2011.08.011","article-title":"Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms","volume":"152","author":"Tsui","year":"2011","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2360","first-page":"1650","article-title":"Insights into the novel function of system Xc- in regulated cell death","volume":"25","author":"Tu","year":"2021","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2365","series-title":"Dictionary of psychological medicine","author":"Tuke","year":"1892"},{"issue":"08","key":"10.1016\/j.pharmthera.2022.108293_bb2370","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis C","volume":"73","author":"Udina","year":"2012","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2375","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918822185","article-title":"xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain","volume":"15","author":"Ungard","year":"2019","journal-title":"Molecular Pain"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2380","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pain.2013.08.030","article-title":"Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain","volume":"155","author":"Ungard","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb2385","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(21)00232-7","article-title":"Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: A systematic review and meta-analysis","volume":"8","author":"Vai","year":"2021","journal-title":"The Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108293_bb2390","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"Journal of Affective Disorders"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb2395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136037","article-title":"Depression dimensions: Integrating clinical signs and symptoms from the perspectives of clinicians and patients","volume":"10","author":"Vares","year":"2015","journal-title":"PLoS One"},{"issue":"04","key":"10.1016\/j.pharmthera.2022.108293_bb2400","first-page":"151","article-title":"The hypothalamic-pituitary-adrenal axis in major depressive disorder","volume":"03","author":"Varghese","year":"2001","journal-title":"The Primary Care Companion to The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2405","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psyneuen.2006.11.009","article-title":"Hypercortisolemic depression is associated with the metabolic syndrome in late-life","volume":"32","author":"Vogelzangs","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb2410","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn1722","article-title":"Astrocytes, from brain glue to communication elements: The revolution continues","volume":"6","author":"Volterra","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"issue":"14","key":"10.1016\/j.pharmthera.2022.108293_bb2415","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1017\/S0033291718000624","article-title":"The prevalence of depression in general hospital inpatients: A systematic review and meta-analysis of interview-based studies","volume":"48","author":"Walker","year":"2018","journal-title":"Psychological Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb2420","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S2215-0366(14)70313-X","article-title":"Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: A cross-sectional analysis of routinely collected clinical data","volume":"1","author":"Walker","year":"2014","journal-title":"The Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2425","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/annonc\/mds575","article-title":"Prevalence of depression in adults with cancer: A systematic review","volume":"24","author":"Walker","year":"2013","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2020.110218","article-title":"Different independent associations of depression and anxiety with survival in patients with cancer","volume":"138","author":"Walker","year":"2020","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2435","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00459","article-title":"Lipidomics in major depressive disorder","volume":"9","author":"Walther","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174396","article-title":"Antidepressant mechanism of catalpol: Involvement of the PI3K\/Akt\/Nrf2\/HO-1 signaling pathway in rat hippocampus","volume":"909","author":"Wang","year":"2021","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2445","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.02.021","article-title":"Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis","volume":"79","author":"Wang","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108293_bb2450","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/glia.23143","article-title":"An astroglial basis of major depressive disorder? An overview","volume":"65","author":"Wang","year":"2017","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2455","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13148-015-0099-8","article-title":"Circulating microRNA-144-5p is associated with depressive disorders","volume":"7","author":"Wang","year":"2015","journal-title":"Clinical Epigenetics"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108293_bb2460","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41380-019-0595-x","article-title":"Depression and anxiety in relation to cancer incidence and mortality: A systematic review and meta-analysis of cohort studies","volume":"25","author":"Wang","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108293_bb2465","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1258\/jrsm.2009.09k038","article-title":"Surgery for the treatment of psychiatric illness: The need to test untested theories","volume":"102","author":"Wessely","year":"2009","journal-title":"Journal of the Royal Society of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbi.2016.08.012","article-title":"Association of inflammation with specific symptoms of depression in a general population of older people: The English longitudinal study of ageing","volume":"61","author":"White","year":"2017","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2475","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jad.2018.08.075","article-title":"Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression","volume":"241","author":"Wilkinson","year":"2018","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108293_bb2480","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1532-5415.2002.50619.x","article-title":"Cytokines and cognition-the case for a head-to-toe inflammatory paradigm","volume":"50","author":"Wilson","year":"2002","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2485","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic acid: The Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions","volume":"8","author":"Wirthgen","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"D1","key":"10.1016\/j.pharmthera.2022.108293_bb2490","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2495","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2500","doi-asserted-by":"crossref","first-page":"25","DOI":"10.31887\/DCNS.2011.13.1\/owolkowitz","article-title":"Of sound mind and body: Depression, disease, and accelerated aging","volume":"13","author":"Wolkowitz","year":"2011","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2505","series-title":"The global burden of disease: 2004 update","author":"World Health Organization Geneva","year":"2008"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108293_bb2515","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00394-018-1667-4","article-title":"Exploring the association between whole blood omega-3 index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education","volume":"58","author":"van der Wurff","year":"2019","journal-title":"European Journal of Nutrition"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2510","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2020.11667","article-title":"Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR-140-5p expression","volume":"23","author":"Wu","year":"2021","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2520","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","article-title":"Tricyclic antidepressants inhibit IL-6, IL-1\u03b2 and TNF-\u03b1 release in human blood monocytes and IL-2 and interferon-\u03b3 in T cells","volume":"34","author":"Xia","year":"1996","journal-title":"Immunopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2525","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ncomms1892","article-title":"Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell","volume":"3","author":"Yae","year":"2012","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2530","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.658340","article-title":"Glymphatic dysfunction: A bridge between sleep disturbance and mood disorders","volume":"12","author":"Yan","year":"2021","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2535","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112750","article-title":"Efficacy and safety of riluzole for depressive disorder: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"284","author":"Yao","year":"2020","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2540","doi-asserted-by":"crossref","first-page":"30659","DOI":"10.1038\/srep30659","article-title":"Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice","volume":"6","author":"Yao","year":"2016","journal-title":"Scientific Reports"},{"issue":"17","key":"10.1016\/j.pharmthera.2022.108293_bb2545","first-page":"4383","article-title":"Glioma cells release excitotoxic concentrations of glutamate","volume":"59","author":"Ye","year":"1999","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108293_bb2550","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/ewjm.173.5.333","article-title":"Depression in medical illness: The role of the immune system","volume":"173","author":"Yirmiya","year":"2000","journal-title":"Western Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2555","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00299","article-title":"Biological mechanisms of cancer-induced depression","volume":"9","author":"Young","year":"2018","journal-title":"Frontiers in Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb2560","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","author":"Y\u00fcksel","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108293_bb2565","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00213-015-3919-9","article-title":"Low-grade inflammation predicts persistence of depressive symptoms","volume":"233","author":"Zalli","year":"2016","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108293_bb2570","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-022-00291-4","article-title":"Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis","volume":"11","author":"Zamani","year":"2022","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2575","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2018.11.001","article-title":"Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders","volume":"172","author":"Zarriello","year":"2019","journal-title":"Progress in Neurobiology"},{"issue":"30","key":"10.1016\/j.pharmthera.2022.108293_bb2580","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1073\/pnas.1410432111","article-title":"Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis","volume":"111","author":"Zhang","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2585","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2020.03.070","article-title":"Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: A role of brain - liver axis","volume":"270","author":"Zhang","year":"2020","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2022.108293_bb2590","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpsychires.2022.02.007","article-title":"A new perspective on depression and neuroinflammation: Non-coding RNA","volume":"148","author":"Zhou","year":"2022","journal-title":"Journal of Psychiatric Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108293_bb2595","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3892\/etm.2020.9602","article-title":"MicroRNA-140-5p regulates the proliferation, apoptosis and inflammation of RA FLSs by repressing STAT3","volume":"21","author":"Zhu","year":"2020","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108293_bb2600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197267","article-title":"Changes in the serum levels of inflammatory cytokines in antidepressant drug-na\u00efve patients with major depression","volume":"13","author":"Zou","year":"2018","journal-title":"PLoS One"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822001875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822001875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:29:36Z","timestamp":1759012176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":520,"alternative-id":["S0163725822001875"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108293","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is depression the missing link between inflammatory mediators and cancer?","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108293"}}